Top

Published in:

Open Access 01-07-2018 | Original Paper

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

Authors: Sarah K. Kaufman, Kelly Del Tredici, Talitha L. Thomas, Heiko Braak, Marc I. Diamond

Published in: Acta Neuropathologica | Issue 1/2018

Abstract

Alzheimer’s disease (AD) is characterized by accumulation of tau neurofibrillary tangles (NFTs) and, according to the prion model, transcellular propagation of pathological “seeds” may underlie its progression. Staging of NFT pathology with phospho-tau antibody is useful to classify AD and primary age-related tauopathy (PART) cases. The locus coeruleus (LC) shows the earliest phospho-tau signal, whereas other studies suggest that pathology begins in the transentorhinal/entorhinal cortices (TRE/EC). The relationship of tau seeding activity, phospho-tau pathology, and progression of neurodegeneration remains obscure. Consequently, we employed an established cellular biosensor assay to quantify tau seeding activity in fixed human tissue, in parallel with AT8 phospho-tau staining of immediately adjacent sections. We studied four brain regions from each of n = 247 individuals across a range of disease stages. We detected the earliest and most robust seeding activity in the TRE/EC. The LC did not uniformly exhibit seeding activity until later NFT stages. We also detected seeding activity in the superior temporal gyrus (STG) and primary visual cortex (VC) at stages before NFTs and/or AT8-immunopositivity were detectable. AD and putative PART cases exhibited similar patterns of seeding activity that anticipated histopathology across all NFT stages. Our findings are consistent with the prion model and suggest that pathological seeding activity begins in the TRE/EC rather than in the LC. In the analysis of tauopathy, quantification of seeding activity may offer an important addition to classical histopathology.

Available only for authorised users

Arnold SE, Toledo JB, Appleby DH, Xie SX, Wang LS, Baek Y et al (2013) Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. J Comp Neurol 521:4339–4355. https://doi.org/10.1002/cne.23430 (PubMed: 23881776) CrossRefPubMed

Barghorn S, Zheng-Fischhöfer Q, Ackmann M, Biernat J, Von Bergen M, Mandelkow EM et al (2000) Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39:11714–11721. https://doi.org/10.1021/bi000850r (PubMed: 10995239) CrossRefPubMed

Bennett RE, deVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J et al (2017) Enhanced tau aggregation in the presence of amyloid β. Am J Pathol 187:1601–1612. https://doi.org/10.1016/j.ajpath.2017.03.011 (PubMed: 28500862) CrossRefPubMedPubMedCentral

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259 (PubMed: 1759558) CrossRefPubMed

Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–278. https://doi.org/10.1016/0197-4580(95)00021-6 (Discussion 278–84; PubMed: 7566337) CrossRefPubMed

Braak H, Del Tredici K (2011) Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol 121:589–595. https://doi.org/10.1007/s00401-011-0825-z (PubMed: 21516512) CrossRefPubMed

Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211. https://doi.org/10.1016/S0197-4580(02)00065-9 (PubMed: 12498954) CrossRefPubMed

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404. https://doi.org/10.1007/s00401-006-0127-z (PubMed: 16906426) CrossRefPubMedPubMedCentral

Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969. https://doi.org/10.1097/NEN.0b013e318232a379 (PubMed: 22002422) CrossRefPubMed

10.

Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–913. https://doi.org/10.1038/ncb1901 (PubMed: 19503072) CrossRefPubMedPubMedCentral

11.

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755–766. https://doi.org/10.1007/s00401-014-1349-0 (PubMed: 25348064) CrossRefPubMedPubMedCentral

12.

Desplats P, Lee HJ, Bae AJ, Patrick C, Rockenstein E, Crews L et al (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010–13015. https://doi.org/10.1073/pnas.0903691106 (PubMed: 19651612) CrossRefPubMedPubMedCentral

13.

Dugger BN, Hidalgo JA, Chiarolanza G, Mariner M, Henry-Watson J, Sue LI et al (2013) The distribution of phosphorylated tau in spinal cords of Alzheimer’s disease and non-demented individuals. J Alzheimers Dis 34:529–536. https://doi.org/10.3233/JAD-121864 (PubMed: 23246918) CrossRefPubMedPubMedCentral

14.

Duyckaerts C, Delatour B, Potier M-C (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5–36. https://doi.org/10.1007/s00401-009-0532-1 (PubMed: 19381658) CrossRefPubMed

15.

Duyckaerts C, Braak H, Brion JP, Buée L, Del Tredici K, Goedert M et al (2015) PART is part of Alzheimer’s disease. Acta Neuropathol 129:749–756. https://doi.org/10.1007/s00401-015-1390-7 (PubMed: 25628035) CrossRefPubMedPubMedCentral

16.

Elobeid A, Soininen H, Alafuzoff I (2012) Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 123:97–104. https://doi.org/10.1007/s00401-011-0906-z (PubMed: 22160320) CrossRefPubMed

17.

Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845–12852. https://doi.org/10.1074/jbc.M808759200 (PubMed: 19282288) CrossRefPubMedPubMedCentral

18.

Furman JL, Holmes BB, Diamond MI (2015) Sensitive detection of proteopathic seeding activity with FRET flow cytometry. J Vis Exp. https://doi.org/10.3791/53205 (PubMed: 26710240) PubMedPubMedCentralCrossRef

19.

Furman JL, Vaquer-Alicea J, White CL 3rd, Cairns NJ, Nelson PT, Diamond MI (2017) Widespread tau seeding activity at early Braak stages. Acta Neuropathol 133:91–100. https://doi.org/10.1007/s00401-016-1644-z (PubMed: 27878366) CrossRefPubMed

20.

Giannakopoulos P, Herrmann FR, Bussière T, Bouras C, Kövari E, Perl DP et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 13:1495–1500 (PubMed: 12743238) CrossRef

21.

Goedert M (2015) Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Aβ, tau, and α-synuclein. Science 349:1255555. https://doi.org/10.1126/science.1255555 (PubMed: 26250687) CrossRefPubMed

22.

Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317–325. https://doi.org/10.1016/j.tins.2010.04.003 (PubMed: 20493564) CrossRefPubMed

23.

Grober E, Dickson D, Sliwinski MJ, Buschke H, Katz M, Crystal H et al (1999) Memory and mental status correlates of modified Braak staging. Neurobiol Aging 20:573–579 (PubMed: 10674422) CrossRefPubMed

24.

Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC et al (2014) Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci 111:E4376–E4385. https://doi.org/10.1073/pnas.1411649111 (PubMed: 25261551) CrossRefPubMedPubMedCentral

25.

Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8:1–13. https://doi.org/10.1016/j.jalz.2011.10.007 (PubMed: 22265587) CrossRefPubMedPubMedCentral

26.

Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer’s-like tauopathy. J Neurosci 33:1024–1037. https://doi.org/10.1523/JNEUROSCI.2642-12.2013 (PubMed: 23325240) CrossRefPubMedPubMedCentral

27.

Kaufman SK, Diamond MI (2013) Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics 10:371–382. https://doi.org/10.1007/s13311-013-0196-3 (PubMed: 23801258) CrossRefPubMedPubMedCentral

28.

Kaufman SK, Sanders DW, Thomas TL, Ruchinskas AJ, Vaquer-Alicea J, Am Sharma et al (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92:796–812. https://doi.org/10.1016/j.neuron.2016.09.055 (PubMed: 27974162) CrossRefPubMedPubMedCentral

29.

Kaufman SK, Thomas TL, Del Tredici K, Braak H, Diamond MI (2017) Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue. Acta Neuropathol Commun 5:41. https://doi.org/10.1186/s40478-017-0442-8 (PubMed: 28587664) CrossRefPubMedPubMedCentral

30.

Kovacs GG (2015) Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41:3–23. https://doi.org/10.1111/nan.12208 (PubMed: 25495175) CrossRefPubMed

31.

Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159. https://doi.org/10.1146/annurev.neuro.24.1.1121 (PubMed: 11520930) CrossRefPubMed

32.

Luk KC, Song C, O’Brien P, Stieber A, Branch JR, Brunden KR et al (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci 106:20051–20056. https://doi.org/10.1073/pnas.0908005106 (PubMed: 19892735) CrossRefPubMedPubMedCentral

33.

Mercken M, Vandermeeren M, Lübke U, Six J, Boons J, Van de Voorde A et al (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84:265–272 (PubMed: 1384266) CrossRefPubMed

34.

Münch C, O’Brien J, Bertolotti A (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci USA 108:3548–3553. https://doi.org/10.1073/pnas.1017275108 (PubMed: 21321227) CrossRefPubMedPubMedCentral

35.

Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D et al (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90:10962–10966 (PubMed: 7902575) CrossRefPubMedPubMedCentral

36.

Ren P-H, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11:219–225. https://doi.org/10.1038/ncb1830 (PubMed: 19151706) CrossRefPubMedPubMedCentral

37.

Safar J, Roller PP, Gajdusek DC, Gibbs CJ (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268:20276–20284 (PubMed: 8104185) PubMed

38.

Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. https://doi.org/10.1016/j.neuron.2014.04.047 (PubMed: 24857020) PubMedPubMedCentralCrossRef

39.

Sanders DW, Kaufman SK, Holmes BB, Diamond MI (2016) Prions and protein assemblies that convey biological information in health and disease. Neuron 89:433–448. https://doi.org/10.1016/j.neuron.2016.01.026 (PubMed: 26844828) CrossRefPubMedPubMedCentral

40.

Sun A, Nguyen XV, Bing G (2002) Comparative analysis of an improved thioflavin-S stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J Histochem Cytochem 50:463–472. https://doi.org/10.1177/002215540205000403 (PubMed: 11897799) CrossRefPubMed

41.

Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800 (PubMed: 12084879) CrossRefPubMed

42.

Tucker KL, Meyer M, Barde Y-A (2001) Neurotrophins are required for nerve growth during development. Nat Neurosci 4:29–37. https://doi.org/10.1038/82868 (PubMed: 11135642) CrossRefPubMed

43.

Uchihara T (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113:483–499. https://doi.org/10.1007/s00401-007-0200-2 (PubMed: 17401570) CrossRefPubMedPubMedCentral

44.

Uchihara T, Giasson BI (2016) Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:49–73. https://doi.org/10.1007/s00401-015-1485-1 (PubMed: 26446103) CrossRefPubMed

45.

Walsh DM, Selkoe DJ (2016) A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci 17:251–260. https://doi.org/10.1038/nrn.2016.13 (PubMed: 26988744) CrossRefPubMedPubMedCentral

Title: Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART
Authors: Sarah K. Kaufman
Kelly Del Tredici
Talitha L. Thomas
Heiko Braak
Marc I. Diamond
Publication date: 01-07-2018
Publisher: Springer Berlin Heidelberg
Published in: Acta Neuropathologica / Issue 1/2018
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-018-1855-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation

Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain

Aging alters the immunological response to ischemic stroke

Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways

Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas